Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Cho

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
The Annals of Thoracic Surgery|October 6, 1999
The Cox-Maze III procedure for atrial fibrillation associated with rheumatic mitral valve diseaseK B Kim, K R Cho, D W Sohn, et al.
Neurosurgery|July 1, 1989
Lipomeningioma: report of three cases and review of the literatureS S Salibi, H J Nauta, H Brem, et al.
The American Journal of Pathology|January 1, 1997
p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesisH Tashiro, C Isacson, R Levine, et al.
Oncogene|December 15, 2000
Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervixR Wu, D Connolly, C Ngelangel, et al.
The American Journal of Pathology|January 1, 1997
Microsatellite instability is uncommon in uterine serous carcinomaH Tashiro, S F Lax, P B Gaudin, et al.
Cancer Research|June 15, 1987
Growth-related elevations of DNA topoisomerase II levels found in Dunning R3327 rat prostatic adenocarcinomasW G Nelson, K R Cho, Y H Hsiang, et al.
The American Journal of Pathology|June 11, 1999
Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in womenC Szych, A Staebler, D C Connolly, et al.
The American Journal of Pathology|April 12, 2002
Diverse tumorigenic pathways in ovarian serous carcinomaGad Singer, Robert J Kurman, Hsueh-Wei Chang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1984
Monocyte receptors for the Fc portion of IgG are increased in systemic lupus erythematosusL F Fries, W W Mullins, K R Cho, et al.
The Journal of Urology|February 1, 1989
Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancerA W Partin, J I Epstein, K R Cho, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
The Annals of Thoracic Surgery|October 6, 1999
The Cox-Maze III procedure for atrial fibrillation associated with rheumatic mitral valve diseaseK B Kim, K R Cho, D W Sohn, et al.
Neurosurgery|July 1, 1989
Lipomeningioma: report of three cases and review of the literatureS S Salibi, H J Nauta, H Brem, et al.
The American Journal of Pathology|January 1, 1997
p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesisH Tashiro, C Isacson, R Levine, et al.
Oncogene|December 15, 2000
Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervixR Wu, D Connolly, C Ngelangel, et al.
The American Journal of Pathology|January 1, 1997
Microsatellite instability is uncommon in uterine serous carcinomaH Tashiro, S F Lax, P B Gaudin, et al.
Cancer Research|June 15, 1987
Growth-related elevations of DNA topoisomerase II levels found in Dunning R3327 rat prostatic adenocarcinomasW G Nelson, K R Cho, Y H Hsiang, et al.
The American Journal of Pathology|June 11, 1999
Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in womenC Szych, A Staebler, D C Connolly, et al.
The American Journal of Pathology|April 12, 2002
Diverse tumorigenic pathways in ovarian serous carcinomaGad Singer, Robert J Kurman, Hsueh-Wei Chang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1984
Monocyte receptors for the Fc portion of IgG are increased in systemic lupus erythematosusL F Fries, W W Mullins, K R Cho, et al.
The Journal of Urology|February 1, 1989
Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancerA W Partin, J I Epstein, K R Cho, et al.
Pageof 8